EX-99.1 2 f6k082416ex99i_nano.htm PRESS RELEASE ISSUED BY NANO DIMENSION LTD. ON AUGUST 24, 2016, ANNOUNCING ITS FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2016

Exhibit 99.1

 

 

 

Nano Dimension Reports Second Quarter Financial Results

 

Ness Ziona, Israel, August 24, 2016 – Nano Dimension Ltd. (NASDAQ, TASE: NNDM), a leader in the area of 3D Printed Electronics, today announced financial results for the second quarter ended June 30, 2016.

 

Nano Dimension ended the second quarter of 2016 with $5,793,000 (NIS 22,278,000) in cash and cash equivalents, while total quarterly expenses were $1,664,000 (NIS 6,401,000).

 

Amit Dror, CEO, said, “We made significant progress during the second quarter and look forward to officially launching the company’s sales strategy in the third quarter. The advancements the company has made over the past quarter include additional patent applications, which we believe will help support our vision that our technology may have various uses – from prototypes for electronics to complex structures for different applications across various industries. As we continue to reach ambitious milestones, we are eager to enter this next phase as we will begin to see the full market demand for our revolutionary printer.”

 

Second Quarter 2016 Financial Results:

 

Research and development (R&D) expenses for the second quarter of 2016 were $503,000 (NIS 1,933,000), compared to $436,000 (NIS 1,642,000) in the first quarter of 2016 and $1,449,000 (NIS 5,571,000) in the second quarter of 2015. The increase compared to the first quarter of 2016 was mainly attributable to an increase of $222,000 (NIS 855,000) in salaries and related personnel expenses, reflecting an increase in the number of employees (the company had 57 R&D employees as of June 30, 2016 and 46 R&D employees as of March 31, 2016).  

 

The R&D expenses for the second quarter of 2016 are presented net of government grants in the amount of $103,000 (NIS 398,000) and net of development expenses recognized as intangible assets in the amount of $1,405,000 (NIS 5,404,000).

 

General and administrative (G&A) expenses for the second quarter of 2016 were $1,197,000 (NIS 4,605,000), compared to $1,176,000 (NIS 4,429,000) in the first quarter of 2016 and $413,000 (NIS 1,590,000) in the second quarter of 2015. The increase compared to the first quarter of 2016 resulted primarily from an increase of $178,000 (NIS 683,000) in professional services expenses mainly for investor relations and legal services.     
   
Net loss for the second quarter of 2016 was $1,664,000 (NIS 6,401,000), or $0.04 (NIS 0.17) per share, compared to $1,790,000 (NIS 6,741,000), or $0.05 (NIS 0.18) per share, in the first quarter of 2016 and $1,848,000 (NIS 7,109,000), or $0.08 (NIS 0.29) per share, in the second quarter of 2015. The change compared to the first quarter of 2016 was due to the changes in the expenses described above, as well as a change in finance expenses due to a change in the exchange rate of the USD against the NIS.   

 

 1 

 

 

Balance Sheet Highlights

 

Cash and cash equivalents totaled $5,793,000 (NIS 22,278,000) as of June 30, 2016, compared to $8,665,000 (NIS 33,811,000) on December 31, 2015. The decrease compared to December 31, 2015 reflects the cash used in operations during the six-month period ended June 30, 2016, net of proceeds received in respect of government grants and net of proceeds received from exercise of warrants during the period.

 

Shareholders' equity totaled $11,558,000 (NIS 44,452,000) as of June 30, 2016, compared to $12,047,000 (NIS 47,004,000) on December 31, 2015.

 

Second Quarter and Recent Corporate Highlights:

  

On May 24, 2016, the company announced that it has been included in the “Cool Vendors in 3D Printing, 2016” report by Gartner, Inc.
   
On May 25, 2016, the company announced that it has successfully lab-tested a proof of concept 3D bioprinter for stem cells. The trial was conducted in collaboration with Accellta Ltd., a company headquartered in Haifa, Israel, that has developed proprietary technologies for the unique production of high quality media, stem cells, progenitors and differentiated cells for drug discovery, regenerative medicine and research. The feasibility study confirmed that the combined know-how and technologies of the companies enabled printing of viable stem cells using an adapted 3D printer.
   
On August 24, 2016, the company announced that it has supplied the first DragonFly 2020 system designated for 3D circuitry and PCBs to a leading defense company in Israel for evaluation purposes. The first supply of the DragonFly 2020 system for testing marked yet another breakthrough for the company. This is the first key step towards the potential commercialization of Nano Dimension’s products.

 

 2 

 

 

 

About Nano Dimension Ltd.

 

Nano Dimension, founded in 2012, focuses on development of advanced 3D printed electronics systems and advanced additive manufacturing. Nano Dimension's unique products combine three advanced technologies: 3D inkjet, 3D software and nanomaterials. The company's primary products include the first 3D printer dedicated to printing multi-layer PCBs (printed circuit boards) and advanced nanotechnology-based conductive and dielectric inks.

 

In addition to the trading of the company's American Depositary Shares on NASDAQ, the company's ordinary shares are also traded on the TASE in Israel. The Bank of New York Mellon serves as the depositary for Nano Dimension. 

 

Forward Looking Statements

 

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal with future events and are based on Nano Dimension's current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of Nano Dimension could differ materially from those described in or implied by the statements in this press release. For example, we are using forward-looking statements when we discuss the commercialization of our products, launching our sales strategy in the third quarter of 2016 and market demand for our printer. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in Nano Dimension’s Annual Report on Form 20-F filed with the Securities and Exchange Commission (“SEC”) on March 8, 2016, and in any subsequent filings with the SEC. Except as otherwise required by law, Nano Dimension undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. 

 

CONTACT INVESTOR RELATIONS: 
Miri Segal-Scharia 
Hayden/ MS-IR LLC 
917-607-8654 
msegal@ms-ir.com

 

 3 

 

 

Nano Dimension Ltd.

 

Consolidated Statements of Financial Position

 

   June 30   June 30   December 31 
   2016   2016   2015 
   Thousand USD
Convenience translation into US dollars
(NIS 3.846 = $1)
   Thousand
NIS
   Thousand
NIS
 
Assets            
Cash and cash equivalents   5,793    22,278    33,811 
Restricted deposits   130    500    500 
Other receivables   419    1,611    1,030 
Total current assets   6,342    24,389    35,341 
                
Restricted deposits   111    425    428 
Property plant and equipment, net   1,393    5,359    4,414 
Intangible assets   5,814    22,361    11,355 
Total non-current assets   7,318    28,145    16,197 
Total assets   13,660    52,534    51,538 
                
Liabilities               
Trade payables   528    2,029    1,727 
Other payables   994    3,824    1,814 
Total current liabilities   1,522    5,853    3,541 
                
Liability in respect of government grants   580    2,229    993 
Total liabilities   2,102    8,082    4,534 
                
Equity               
Share capital   1,135    4,367    3,863 
Share premium   18,976    72,980    63,054 
Treasury shares   (1,368)   (5,260)   (5,260)
Warrants   896    3,445    6,934 
Capital reserve from transactions with controlling shareholders   485    1,866    1,866 
Capital reserve for share-based payments   4,246    16,330    12,681 
Accumulated loss   (12,812)   (49,276)   (36,134)
Total equity   11,558    44,452    47,004 
Total liabilities and equity   13,660    52,534    51,538 

 

 4 

 

 

Nano Dimension Ltd.

 

Consolidated Statements of Profit or Loss and Other Comprehensive Income

 

   For the six months ended
June 30
   For the three months ended
June 30
   For the year ended December 31 
   2016   2016   2015   2016   2016   2015   2015 
  Thousand USD
Convenience translation into US dollars
(NIS 3.846 = $1)
   Thousand NIS   Thousand NIS   Thousand USD
Convenience translation into US dollars
(NIS 3.846 = $1)
   Thousand NIS   Thousand NIS   Thousand NIS 
                             
Research and development expenses, net   930    3,575    7,492    503    1,933    5,571    11,153 
General and administrative expenses   2,349    9,034    2,613    1,197    4,605    1,590    11,229 
Other income   -    -    -    -    -    -    6 
Operating loss   (3,279)   (12,609)   (10,105)   (1,700)   (6,538)   (7,161)   (22,376)
                                    
Finance income   -    -    138    36    137    191    1,529 
Finance expense   138    533    189    -    -    139    145 
                                    
Total comprehensive loss   (3,417)   (13,142)   (10,156)   (1,664)   (6,401)   (7,109)   (20,992)
                                    
Basic and diluted loss per share (in NIS / USD)   (0.09)   (0.35)   (0.45)   (0.04)   (0.17)   (0.29)   (0.78)

 

 5 

 

 

Nano Dimension Ltd.

 

Consolidated Statements of Changes in Equity

 

   Share capital   Share premium   Treasury shares   Warrants   Capital reserve from transactions with controlling shareholders   Capital reserve for share- based payments   Accumulated loss   Total equity  

Convenience translation into US dollars

(NIS 3.846 = $1)

 
   Thousand NIS   Thousand NIS   Thousand NIS   Thousand NIS   Thousand NIS   Thousand NIS   Thousand NIS   Thousand NIS   Thousand
USD
 
For the six months ended June 30, 2016:                                    
Balance as of January 1, 2016   3,863    63,054    (5,260)   6,934    1,866    12,681    (36,134)   47,004    12,221 
Exercise of warrants and options   504    9,926    -    (3,489)   -    (1,353)   -    5,588    1,453 
Share-based payments   -    -    -    -    -    5,002    -    5,002    1,301 
Net loss   -    -    -    -    -    -    (13,142)   (13,142)   (3,417)
                                              
Balance as of June 30, 2016   4,367    72,980    (5,260)   3,445    1,866    16,330    (49,276)   44,452    11,558 
                                              
For the three months ended June 30, 2016:                                             
Balance as of April 1, 2016   4,267    69,817    (5,260)   4,623    1,866    14,393    (42,875)   46,831    12,176 
Exercise of warrants and options   100    3,163    -    (1,178)   -    (208)   -    1,877    488 
Share-based payments   -    -    -    -    -    2,145    -    2,145    558 
Net loss   -    -    -    -    -    -    (6,401)   (6,401)   (1,664)
                                              
Balance as of June 30, 2016   4,367    72,980    (5,260)   3,445    1,866    16,330    (49,276)   44,452    11,558 

 

 

6